Medicine and Dentistry
Anemia
13%
Bariatric Surgery
56%
Body Mass Index
26%
Cancer
14%
Chemoradiotherapy
32%
Cholecystitis
30%
Cholecystostomy
26%
Colectomy
32%
Colon Carcinoma
28%
Comorbidity
11%
Computer Assisted Tomography
11%
Consolidation Chemotherapy
15%
Cytoreductive Surgery
27%
Disease Free Survival
34%
Diseases
31%
Elderly Patient
11%
Fascia
15%
Gastric Bypass
31%
Gastric Bypass Surgery
31%
Gastroesophageal Reflux
12%
Gastrointestinal Stromal Tumor
20%
Hernia
13%
Induction Chemotherapy
14%
Intraperitoneal Chemotherapy
30%
Iron
15%
Laparoscopic Cholecystectomy
25%
Laparoscopic Sleeve Gastrectomy
35%
Laparoscopic Surgery
12%
Laparotomy
22%
Lymph Node
25%
Magnetic Resonance Imaging
40%
Metastatic Colon Cancer
11%
Minoxidil
11%
Neoadjuvant Therapy
85%
Neoplasm
78%
Obesity Medicine
24%
Overall Survival
26%
Peritoneum Metastasis
20%
Postoperative Complication
12%
Primary Tumor
45%
Quality of Life
12%
Rectum Cancer
100%
Rectum Carcinoma
39%
Recurrent Disease
15%
Retrospective Cohort Study
11%
Sleeve Gastrectomy
43%
Surgeon
44%
Surgical Anastomosis
47%
Surgical Staple
12%
Total Mesorectal Excision
22%
Keyphrases
Acalculous Cholecystitis
30%
Anemia
13%
Bariatric Surgery
63%
Between-group
12%
Body Mass Index
19%
Chemoradiation
22%
Clinical Response
18%
Colon Adenocarcinoma
13%
Colon Cancer
15%
Colorectal Cancer
92%
Consolidation Chemotherapy
15%
Cytoreductive Surgery
27%
Delayed Cholecystectomy
20%
Disease-free Survival
35%
Elderly Patients
12%
Emergency Laparotomy
20%
Gastrointestinal Stromal Tumor
20%
Induction Chemotherapy
14%
Intraperitoneal Chemotherapy
20%
Israeli Society
23%
Laparoscopic Sleeve Gastrectomy
37%
Length of Stay
27%
Metabolic Surgery
44%
Morbidly Obese Patients
15%
Neoadjuvant Therapy
20%
Nonoperative Management
22%
Oncological Outcomes
23%
One Anastomosis
20%
One-anastomosis Gastric Bypass
34%
Organ Preservation
66%
Overall Survival
26%
Percutaneous Cholecystostomy
25%
Peritoneal Metastasis
20%
Postoperative Outcomes
26%
Primary Tumor
21%
Primary Tumor Location
20%
Radiologists
14%
Rectal Adenocarcinoma
44%
Restaging
17%
Restaging MRI
14%
Retrospective Analysis
24%
Revisional
15%
Sleeve Gastrectomy
43%
Surgeons
16%
Surgical Treatment
16%
Total Neoadjuvant Therapy
62%
Transanal Total Mesorectal Excision (taTME)
22%
Tumor
34%
Tumor Outcome
20%
Watch-and-wait
28%